Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allium Cepa for Post-Stroke Shoulder Pain
NCT03468049Phase 1Completed
- Sponsor
- Bayero University Kano
- Start
- Jun 2018
- Primary completion
- Jun 2019
- Modality
- Herbal Medicine, Dietary Supplement, Homeopathic Remedy
- Countries
- 1
01
Overview
Phase 1, randomised trial of Allium cepa in hemiplegic shoulder pain (PHS) (4 arms), sponsored by Bayero University Kano. Primary endpoints: Visual Analogue Scale at 12 weeks and Fugl Meyer Assessment at 12 weeks. Started Jun 2018; status: completed.
02
Drugs
Allium cepa
03
Conditions
hemiplegic shoulder pain (PHS)
Beyond the preview
Go deeper on NCT03468049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03468049.